Milton-Laskibar Iñaki, Aguirre Leixuri, Fernández-Quintela Alfredo, Rolo Anabela P, Soeiro Teodoro João, Palmeira Carlos M, Portillo María P
Nutrition and Obesity Group, Department of Nutrition and Food Science, University of the Basque Country (UPV/EHU) and Lucio Lascaray Research Institute, Facultad de Farmacia, Vitoria 01006, Spain.
CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Vitoria 01006, Spain.
Nutrients. 2017 Jul 11;9(7):737. doi: 10.3390/nu9070737.
The aims of the present study were to analyze the effect of resveratrol on liver steatosis in obese rats, to compare the effects induced by resveratrol and energy restriction and to research potential additive effects. Rats were initially fed a high-fat high-sucrose diet for six weeks and then allocated in four experimental groups fed a standard diet: a control group, a resveratrol-treated group, an energy restricted group and a group submitted to energy restriction and treated with resveratrol. We measured liver triacylglycerols, transaminases, FAS, MTP, CPT1a, CS, COX, SDH and ATP synthase activities, FATP2/FATP5, DGAT2, PPARα, SIRT1, UCP2 protein expressions, ACC and AMPK phosphorylation and PGC1α deacetylation. Resveratrol reduced triacylglycerols compared with the controls, although this reduction was lower than that induced by energy restriction. The mechanisms of action were different. Both decreased protein expression of fatty acid transporters, thus suggesting reduced fatty acid uptake from blood stream and liver triacylglycerol delivery, but only energy restriction reduced the assembly. These results show that resveratrol is useful for liver steatosis treatment within a balanced diet, although its effectiveness is lower than that of energy restriction. However, resveratrol is unable to increase the reduction in triacylglycerol content induced by energy restriction.
本研究的目的是分析白藜芦醇对肥胖大鼠肝脏脂肪变性的影响,比较白藜芦醇和能量限制所诱导的效应,并研究潜在的相加效应。大鼠最初喂食高脂高糖饮食六周,然后分为四组喂食标准饮食的实验组:对照组、白藜芦醇处理组、能量限制组以及接受能量限制并经白藜芦醇处理的组。我们测量了肝脏三酰甘油、转氨酶、脂肪酸合酶(FAS)、微粒体甘油三酯转运蛋白(MTP)、肉碱棕榈酰转移酶1a(CPT1a)、柠檬酸合酶(CS)、细胞色素氧化酶(COX)、琥珀酸脱氢酶(SDH)和ATP合酶的活性,脂肪酸转运蛋白2/脂肪酸转运蛋白5(FATP2/FATP5)、二酰甘油酰基转移酶2(DGAT2)、过氧化物酶体增殖物激活受体α(PPARα)、沉默信息调节因子1(SIRT1)、解偶联蛋白2(UCP2)的蛋白表达,乙酰辅酶A羧化酶(ACC)和腺苷酸活化蛋白激酶(AMPK)的磷酸化以及过氧化物酶体增殖物激活受体γ共激活因子1α(PGC1α)的去乙酰化。与对照组相比,白藜芦醇降低了三酰甘油水平,尽管这种降低低于能量限制所诱导的降低。其作用机制不同。二者均降低了脂肪酸转运蛋白的蛋白表达,从而提示从血流中摄取的脂肪酸减少以及肝脏三酰甘油的输送减少,但只有能量限制降低了组装。这些结果表明,在均衡饮食中,白藜芦醇对肝脏脂肪变性的治疗有用,尽管其疗效低于能量限制。然而,白藜芦醇无法增强能量限制所诱导的三酰甘油含量的降低。